
Skipta + NorstellaLinQ: Finding the 8% of Oncologists Testing for Breast Cancer Candidates, and Reaching the 92% Who Aren’t
In this case study, discover how Skipta and the NorstellaLinQ real-world data foundation identified the oncologists at the gateway to treatment, and how the brand can now message testers and non-testers differently.











